Biocon Out-Licenses Semaglutide to Ajanta Pharma for Emerging Markets, Expanding GLP-1 Footprint
Bengaluru-headquartered Biocon Limited has entered into an out-licensing agreement with Ajanta Pharma Ltd to commercialise its GLP-1–based anti-diabetes therapy Semaglutide […]
